Results 131 to 140 of about 12,276 (270)

Identifying Neurotechnology Challenges at NeuroCAS [PDF]

IEEE Pulse, 2019
The second NeuroCAS event held 20-21 October 2018 in Cleveland, OH, USA, was attended by researchers and entrepreneurs across the fields of biosignals and neurotechnology. On the heels of the IEEE BioCAS Conference, the intent of this collaborative workshop was to offer an opportunity for those within the larger biomedical circuits and systems ...
openaire   +2 more sources

Prolonged ictal and post‐ictal central apnea in an epileptic seizure

Epileptic Disorders, EarlyView.
Wei Zhao, Alena Berkhamova, Rabeha Noor, Abdulrahman Alwaki, Elli Allen   +4 more
wiley   +1 more source

Neurorights vs. neuroprediction and lie detection: The imperative limits to criminal law

Frontiers in Psychology, 2022
José Manuel Díaz Soto, Diego Borbón
doaj   +1 more source

Le cerveau, dernier refuge des droits et libertés fondamentaux

Cahiers Droit, Sciences & Technologies
Neurotechnological advances open up unprecedented opportunities to access and modify brain data, thereby contributing to the prevention, diagnosis, and treatment of neurological diseases and disorders. However, these same technologies raise unprecedented
Roberto Andorno
doaj   +1 more source

Managing the Ethical Dimensions of Brain-Computer Interfaces in eHealth: An SDLC-based Approach [PDF]

, 2016
A growing range of brain-computer interface (BCI) technologies is being employed for purposes of therapy and human augmentation. While much thought has been given to the ethical implications of such technologies at the ‘macro’ level of social policy and ‘
Gladden, Matthew E.
core  

Continuous Apomorphine Infusion in Multiple System Atrophy Real‐World Insights From a French Nationwide Retrospective Cohort

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Continuous subcutaneous apomorphine infusion (CSAI) is effective in Parkinson's disease but has not been evaluated in multiple system atrophy (MSA). Objective To assess the 6‐month efficacy and tolerability of CSAI in MSA patients. Methods French multicenter retrospective registry‐based analysis of CSAI use in MSA.
Simon Lamy, Frederique Leh, Alexandra Foubert‐Samier, Soizic Leguy Bonnet, Guillaume Baille, Margherita Fabbri, Margaux Dunoyer, Lise Mantisi, Caroline Giordana, Anaïs El Ouartassi, Olivier Rascol, Wassilios G. Meissner, David Bendetowicz, Marie Vanel, David Grabli, Fabienne Ory‐Magne, Sophie Drapier   +16 more
wiley   +1 more source

The Feasibility of Neuroimaging Methods in Marketing Research [PDF]

, 2009
On July 17, 1990, President George Bush issued “Proclamation #6158” which boldly declared the following ten years would be called the “Decade of the Brain” (Bush, 1990).
Carl Senior, Michael Butler, Nick Lee, Ricardo Fuchs   +3 more
core   +1 more source

Sustainability in Healthcare: The Role of Digital Technologies for Improving Patient Engagement

Business Ethics, the Environment &Responsibility, EarlyView.
ABSTRACT Sustainability in healthcare is getting considerable research attention as systems worldwide tend to balance environmental, social, and economic factors. In this context, digital technologies have demonstrated significant potential to enhance engagement among different consumer groups across various industries.
Francesco Schiavone, Federica Zeuli, Olga Grieva, Octavio Escobar, Fabian Bernhard   +4 more
wiley   +1 more source

Contextualising Mental Privacy in South Africa: Legal, Ethical, and Socio‐Cultural Considerations With Policy Recommendations

Developing World Bioethics, EarlyView.
ABSTRACT Mental privacy is a growing concern as neurotechnologies and digital mental health tools collect and process sensitive brain‐related data. In South Africa, cultural and religious diversity adds complexity to protecting mental privacy, with traditional healing practices, communal decision‐making, and spiritual beliefs influencing mental health ...
Marietjie Botes, Melodie Labuschaigne, Camille Casteleyn, Becky Inkster, Mark Sheppard   +4 more
wiley   +1 more source

Effect of Acoustic Pressure on Temozolomide-Loaded Oleic Acid-Based Liposomes and Its Safety to Brain Tissue

Pharmaceuticals
Background: Glioblastoma (GBM) is a highly aggressive primary brain tumor with limited therapeutic options, particularly due to the limited blood–brain barrier (BBB) permeability.
Vasilisa D. Dalinina, Vera S. Shashkovskaya, Iman M. Khaskhanova, Daria Yu. Travnikova, Nelly S. Chmelyuk, Dmitry A. Korzhenevskiy, Vsevolod V. Belousov, Tatiana O. Abakumova   +7 more
doaj   +1 more source